(Q45972156)

18 December 2017

title

Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis. (English)

1 reference

18 December 2017

1 reference

8

Jacques H Grosset

1 reference

18 December 2017

Eric Nuermberger

9

object named as

Eric L Nuermberger

1 reference

18 December 2017

author name string

Kathy N Williams

1

1 reference

18 December 2017

Steven J Brickner

2

1 reference

18 December 2017

Charles K Stover

3

1 reference

18 December 2017

Tong Zhu

4

1 reference

18 December 2017

Adam Ogden

5

1 reference

18 December 2017

Rokeya Tasneen

6

1 reference

18 December 2017

Sandeep Tyagi

7

1 reference

18 December 2017

language of work or name

English

0 references

publication date

11 June 2009

1 reference

18 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

18 December 2017

volume

180

1 reference

18 December 2017

issue

4

1 reference

18 December 2017

page(s)

371-376

1 reference

18 December 2017

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Linezolid for the treatment of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Bioavailability of rifampin in experimental murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Pharmacokinetics and tissue penetration of linezolid following multiple oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0611OC

10.1164/RCCM.200904-0611OC

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

release_aignpo2x4vg6jokrt7ouydkegi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aignpo2x4vg6jokrt7ouydkegi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

18 December 2017